Our Award Winning COVID-19 Product
World Artificial Intelligence Conference (WAIC)

At the WAIC 2020 held in Shanghai, BioMind has been awarded for her excellent performance and her contribution in the fight against COVID-19 pandemic.

Slider
Our Award Winning COVID-19 Product
World Artificial Intelligence Conference (WAIC)
At the WAIC 2020 held in Shanghai, BioMind has been awarded for her excellent performance and her contribution in the fight against COVID-19 pandemic.
Slider
OUR APPLICATIONS
  • DIAGNOSTIC IMAGING
  • CDSS SYSTEM
  • DEEP GENOMICS

AI for Neurological Disorders

AI for Neurological Disorders

CE marked, NMPA and HSA approved. 

Our flagship AI application for the brain integrates deep learning technology with vast clinical knowledge to assist in the diagnosis of neurological disorders on MRI and CT scans. 

A wide range of conditions that can be detected and analysed include brain tumours, cerebral vessel diseases and stroke.

AI for COVID-19 Pneumonia

AI for COVID-19 Pneumonia

Indonesia MOH, Thai FDA and HSA approved.

It is able to detect COVID-19 pneumonia on CT scans in seconds and has a triage function for early intervention.

It can also differentiate COVID-19 pneumonia from other types of pneumonia, facilitating automated disease progression evaluation for fast and easy patient management.

AI for Cardiac Diseases

AI for Cardiac Diseases

For Research Use ONLY.

Currently in its research phase, the early breakthroughs in using deep learning on MRI and ultrasound scans for accurate analysis of the heart as well as assist in differential diagnosis of heart diseases, enables early detection and management of complex heart problems.

Acute ischemic stroke is a disease that can result in high morbidity, disability, mortality and recurrence. It remains as the leading cause of death in many countries.

Our Stroke Clinical Decision Support System (CDSS), Stroke-AITM leverages the use of Artificial Intelligence to assist doctors by recommending diagnosis and treatment plans for ischemic stroke patients.

Stroke-AITM also serves to improve treatment quality and facilitate the standardisation of stroke patient management. This solution is currently undergoing clinical trials in 50 hospitals.

Precision Drug with Deep Genomics

Precision Drug with Deep Genomics

Discovering responsible gene-sets for diseases such as cancer and vascular deformation from large genomic information is an important step in understanding these complex diseases today.

Man has only interpreted 3% of our genomic information, there is still a huge amount of information that calls for new technology to speed up our interpretation efficiency.

We develop deep learning technology to pinpoint responsible gene-sets and alleles and discover new drugs that can target these mutations to assist in precise treatment.

  • AI Image Analysis
  • CISS Stroke Breakdown
  • Suggestions for diagnosis and treatment
  • Stroke Risk Management

Precision Drug with Deep Genomics

Discovering responsible gene-sets for diseases such as cancer and vascular deformation from large genomic information is an important step in understanding these complex diseases today.

Man has only interpreted 3% of our genomic information, there is still a huge amount of information that calls for new technology to speed up our interpretation efficiency.

We develop deep learning technology to pinpoint responsible gene-sets and alleles and discover new drugs that can target these mutations to assist in precise treatment.
  • AI image analysis
  • CISS stroke breakdown
  • Suggestions for diagnosis and treatment
  • Stroke risk management

In a world where sustainable healthcare has become essential, the demand for innovative healthcare solutions is at an all time high.

Dr Gauden Galea
World Health Organisation representative in China

“AI tech like BioMind® could aid doctors in rural areas, enabling their residents to access quality healthcare. Take this technology and deliver it to a rural health district and you've suddenly got a magical enhancement that gives doctors there the ability to diagnose”

Dr Ma Lin
Chairman and Professor, Department of Radiology, Chinese PLA General Hospital, Beijing, China

It is of great importance that we leverage the strength of AI on the detection of COVID-19 infection on CT imaging, enabling us to identify infected patients early, isolate early and treat early.”

Dr Paul Parizel
Former President of the European Society of Radiology

“AI like BioMind would eventually become integrated into existing medical work flow environments, like a GPS navigation system guiding the driver of a car"

Dr Tchoyoson Lim
Senior Consultant, National Neuroscience Institute, ​Department of Neuroradiology ​

“BioMind has been very well trained and achieved very impressive results. AI technology like BioMind could help make a preliminary judgement on what condition a patient has, which doctors could then review. With a machine like this to help us, doctors would be able to serve patients better.”​

Dr Niedercorn
Chief Radiologist at HRS ​

"In addition to the detection of COVID 19 lung damage, if this algorithm can allow us to
quantitatively and objectively assess the lung volumes affected and their evolutionary monitoring over time, this can positively impact on the better management of our patients."

Slider
Dr Gauden Galea
World Health Organisation representative in China

“AI tech like BioMind® could aid doctors in rural areas, enabling their residents to access quality healthcare. Take this technology and deliver it to a rural health district and you've suddenly got a magical enhancement that gives doctors there the ability to diagnose”

Dr Ma Lin
Chairman and Professor, Department of Radiology, Chinese PLA General Hospital, Beijing, China

It is of great importance that we leverage the strength of AI on the detection of COVID-19 infection on CT imaging, enabling us to identify infected patients early, isolate early and treat early.”

Dr Paul Parizel
Former President of the European Society of Radiology

“AI like BioMind would eventually become integrated into existing medical work flow environments, like a GPS navigation system guiding the driver of a car"

Dr Tchoyoson Lim
Senior Consultant, National Neuroscience Institute, ​Department of Neuroradiology ​

“BioMind has been very well trained and achieved very impressive results. AI technology like BioMind could help make a preliminary judgement on what condition a patient has, which doctors could then review. With a machine like this to help us, doctors would be able to serve patients better.”​

Dr Niedercorn
Chief Radiologist at HRS ​

"In addition to the detection of COVID 19 lung damage, if this algorithm can allow us to quantitatively and objectively assess the lung volumes affected and their evolutionary monitoring over time, this can positively impact on the better management of our patients."

Slider

+65 6821 1272

BioMind Offices

+65 6821 1272

BioMind Offices

China

Beijing BioMind Technology, Zhongguancun Medical Engineering Center, 10 Anxiang Road, 8th floor

Singapore

Hanalytics Pte Ltd 151 Lorong Chuan #03-01C, Lobby A, New Tech Park, Singapore 556741

Europe

Hanalytics SARL House of Biohealth 27-29, rue Henri Koch, L-4354 Esch/Alzette,Luxembourg

Copyright © 2020 BioMind All Rights Reserved | ISO 13485:2016 Certified Organisation | Privacy Policy | Terms of Use

Book Demo

Our staff will contact you as soon as possible.
Looking forward to meeting you!

Products you are interested in

预定演示

当您提交后,我们的工作人员将尽快与您联系并安排演示,期待与您见面!

您感兴趣的产品

CONTACT US

联系我们